资讯

中山眼科中心临床研究中心第15期临床研究系列讲座

点击上方“公众号”可订阅哦！

第15期临床研究讲座将于2016年6月20日（周一）下午15:30在中山眼科中心3号楼2楼讲学厅举行。本期讲座将邀请著名临床研究专家，现任ARVO主席Prof Emily Chew和NIH荣休教授陈之昭出席演讲，欢迎参加。

Emily Y. Chew, M.D

◆ The current ARVO president

◆ Deputy Director, Division of Epidemiology and Clinical Applications, National Eye Institute

◆ Deputy Clinical Director, National Eye Institute

◆ Chief of Clinical Trials Branch, National Eye Institute

Prof Chew research interest includes phase I/II clinical trials and epidemiologic studies in retinovascular diseases such as age-related macular degeneration, diabetic retinopathy, ocular diseases of von Hippel-Lindau Disease and others.

She worked extensively in large multi-centered trials headed by the staff of NEI/NIH including the Early Treatment Diabetic Retinopathy Study (ETDRS) and the Age-Related Eye Disease Study (AREDS). She chairs the Actions to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, testing the effects of tight control of blood sugar, blood pressure and lipid concentration in the blood on diabetic eye disease. She is also the study chair for the Age-Related Eye Disease Study 2 (AREDS2), a Phase 3 study that is investigating the use of lutein/zeaxanthin (found in leafy greens such as kale) and/or omega-3 polyunsaturated fatty acids as treatment for age-related macular degeneration (AMD) and cataracts.

Chi-Chao Chan, M.D

◆ Scientist Emerita, National Institutes of Health (2015.06-current)

◆ Chief, Section on Immunopathology, Laboratory of Immunology, National Eye Institute (1992-2015)

◆ Chief, Histology Core, National Eye Institute (1999-2015)

◆ Honorary Director of Zhongshan Ophthalmic Center(ZOC)

Prof Chan has had extensive experience in ophthalmic pathology and clinical ocular immunology. Dr. Chan is a world expert in intraocular lymphoma, immunopathology of uveitis, molecular pathology of age-related macular degeneration (AMD), ocular lymphoma and von Hippel-Lindau disease. Due to her studies she has provided the health field with a deeper understanding of the development of these diseases. In addition to her research, Dr. Chan continues to help patients manage with eye diseases. Currently, she is involved in studies surrounding intraocular lymphoma, uveitis, and the genetics of AMD.

本讲座公益免费，无需报名，直赴现场即可

【信息】北上广三地伦理秘书共识 ——药物和器械临床试验伦理审查递交资料清单与自查要点

由于国内各伦理委员会的要求不同，在申请临床试验伦理审查时，所需要提交的审查资料也各不相同。这种状况不仅给申办方递交伦理审查带来困扰，同时影响临床试验尤其是多中心临床试验的伦理审查效率。为最大限度统一各伦理委员会对于临床试验伦理初始审查资料的要求，2019年6月在上海召开了北上广三地伦理秘书论坛，聚焦伦理形式审查的主要内容及审查要点。会上，参会代表在前期北京、上海和广州分别召开的伦理秘书沙龙的基础上，围绕药物和器械临床试验伦理审查递交资料清单与自查要点进行逐条讨论，并就样本外送的说明、试验保险等进行了重点探讨。三地伦理委员会代表最终协商并确认了药物和医疗器械临床试验的伦理审查递交资料清单与自查要点共识1.0版。

本次北上广三地伦理秘书论坛促进了伦理委员会的同质化建设，并为伦理审查互认工作的推进建立了基础。

[参加人员]：白楠（解放军总医院）、白胜（广东省人民医院）、程潇（上海市第六人民医院）、陈倩倩（上海长征医院）、陈晓云（上海龙华医院）、崔焱（北京友谊医院）、陈仲林（上海胸科医院）、耿雯倩（上海市第一人民医院）、洪雪（北京大学第三医院）、黄琦程（上海新华医院）、胡兴媛（广州南方医院）、江一峰（上海市第一人民医院）、李淑娟（解放军总医院第五医学中心）、李晓彦（广东省中医院）、李媛媛(湛江中心人民医院)、刘晓茜（上海公共卫生临床中心）、陆麒（上海仁济医院）、盛艾娟（北京佑安医院）、时涛（深圳市第二人民医院）、王佳乐（北京协和医院）、王晶（北京中医医院）、位华（上海长征医院）、吴大维（中国医学科学院肿瘤医院）、许俊羽（北京大学第一医院）、杨红荣（上海交通大学医学院）、杨梦婕（上海中山医院）、张玮静（上海肿瘤医院）、张海洪（北京大学医学部）、张卓然（北京宣武医院）、张怡（孙逸仙纪念医院）、訾明杰（北京西苑医院）、赵励彦（北京大学医学部）、周运翱（北京地坛医院）

[审阅人员]：白彩珍（北京天坛医院）、白桦（北京协和医院）、陈勇川（西南医院）、梁伟雄（广东省中医院）、沈一峰（上海市精神卫生中心）、许重远（南方医院）、王美霞（北京佑安医院）、汪秀琴（江苏省人民医院）

【预告】第15期临床研究系列讲座

点击上方“公众号”可订阅哦！

第15期临床研究系列讲座将于2016年6月20日（周一）下午15:30在中山眼科中心3号楼2楼讲学厅举行。本期讲座将邀请著名临床研究专家，现任ARVO主席Prof Emily Chew和NIH荣休教授陈之昭出席演讲，欢迎参加。

Emily Y. Chew, M.D

◆ The current ARVO president

◆ Deputy Director, Division of Epidemiology and Clinical Applications, National Eye Institute

◆ Deputy Clinical Director, National Eye Institute

◆ Chief of Clinical Trials Branch, National Eye Institute

Dr. Chew is the director of the medical retina fellowship program at the NEI.She is working on a large clinical trial called the Actions to Control Cardiovascular Risk in Diabetes (ACCORD), testing the effects of tight control of blood sugar, blood pressure and lipid concentration in the blood on diabetic eye disease.

Currently, Dr. Chew is the study chair for the Age-Related Eye Disease Study 2 (AREDS2), a Phase 3 study that is investigating the use of lutein/zeaxanthin (found in leafy greens such as kale) and/or omega-3 polyunsaturated fatty acids as treatment for age-related macular degeneration (AMD) and cataracts.

Chi-Chao Chan, M.D

◆ Scientist Emerita, National Institutes of Health (2015.06-current)

◆ Chief, Section on Immunopathology, Laboratory of Immunology, National Eye Institute (1992-2015)

◆ Chief, Histology Core, National Eye Institute (1999-2015)

Prof Chan has had extensive experience in ophthalmic pathology and clinical ocular immunology. She is a world expert in intraocular lymphoma, immunopathology of uveitis, molecular pathology of age-related macular degeneration (AMD), ocular lymphoma and von Hippel-Lindau disease. Due to her studies she has provided the health field with a deeper understanding of the development of these diseases. In addition to her research, Dr. Chan continues to help patients manage with eye diseases. Currently, she is involved in studies surrounding intraocular lymphoma, uveitis, and the genetics of AMD.

本讲座公益免费，无需报名，直赴现场即可